FAIRMOUNT FUNDS MANAGEMENT
Fairmount Funds Management is a Philadelphia-based investment firm.
FAIRMOUNT FUNDS MANAGEMENT
Industry:
Financial Services
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Chicago Fundamental Investment Partners (CFIP)
Chicago Fundamental Investment Partners ("CFIP") is a credit focused investment management firm.
Fenway Sports Management
Fenway Sports Management is a company headquartered in Boston,
Lincoln Park Capital Fund
Lincoln Park Capital Fund is a Chicago-based asset management firm focused on opportunistic investing in public and private companies.
Scion Asset Management
Scion Asset Management®, LLC is a private investment firm founded and led by Dr. Michael J. Burry.
Walden International
Walden International is a venture capital firm.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-12 | Terns Pharmaceuticals | Fairmount Funds Management investment in Post-IPO Equity - Terns Pharmaceuticals | 65 M USD |
| 2022-07-08 | Annexon Biosciences | Fairmount Funds Management investment in Post-IPO Equity - Annexon Biosciences | 130 M USD |
| 2022-06-09 | DBV Technologies | Fairmount Funds Management investment in Post-IPO Equity - DBV Technologies | 181 M EUR |
| 2022-04-19 | Dianthus Therapeutics | Fairmount Funds Management investment in Series A - Dianthus Therapeutics | 100 M USD |
| 2022-04-07 | Trevi Therapeutics | Fairmount Funds Management investment in Post-IPO Equity - Trevi Therapeutics | 55 M USD |
| 2021-07-01 | Point Biopharma | Fairmount Funds Management investment in Post-IPO Equity - Point Biopharma | 165 M USD |
| 2021-05-18 | Interius BioTherapeutics | Fairmount Funds Management investment in Series A - Interius BioTherapeutics | 76 M USD |
| 2021-05-11 | Nuvalent | Fairmount Funds Management investment in Series B - Nuvalent | 135 M USD |
| 2020-07-17 | Verona Pharma | Fairmount Funds Management investment in Post-IPO Equity - Verona Pharma | 200 M USD |
| 2020-07-06 | Cogent Biosciences | Fairmount Funds Management investment in Post-IPO Equity - Cogent Biosciences | 104.4 M USD |